LIST OF TABLES
UU
TABLE 1 MENTAL ILLNESS IN U.S. ADULTS IN 2018 34
TABLE 2 MENTAL DISORDERS IN THE U.S. ADULTS IN 2018 35
TABLE 3 MENTAL DISORDERS CAUSED BY USAGE OF SUBSTANCE DISORDERS IN WORLD IN 2017 39
TABLE 4 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS 43
TABLE 5 COST OF PSYCHEDELIC DRUGS 45
TABLE 6 PSYCHEDELIC DRUGS R&D ACTIVITIES 46
TABLE 7 U.S. PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2018-2027 (USD MILLION) 54
TABLE 8 U.S. PSYCHEDELIC DRUGS MARKET, BY TYPE, 2018-2027 (USD MILLION) 58
TABLE 9 U.S. PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 62
TABLE 10 U.S. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION) 68
TABLE 11 U.S. PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2018-2027 (USD MILLION) 73
TABLE 12 U.S. PSYCHEDELIC DRUGS MARKET, BY END USER, 2018-2027 (USD MILLION) 78
TABLE 13 U.S. PSYCHEDELIC DRUGS MARKET, BY END USER, 2018-2027 (VOLUME IN 100ML) 79
TABLE 14 U.S. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION) 83
LIST OF FIGURE
LIST OF FIGURES
FIGURE 1 U.S. PSYCHEDELIC DRUGS MARKET: SEGMENTATION 13
FIGURE 2 U.S. PSYCHEDELIC DRUGS MARKET: DATA TRIANGULATION 15
FIGURE 3 U.S. PSYCHEDELIC DRUGS MARKET: DROC ANALYSIS 16
FIGURE 4 U.S. PSYCHEDELIC DRUGS MARKET : COUNTRY VS REGIONAL MARKET ANALYSIS 17
FIGURE 5 U.S. PSYCHEDELIC DRUGS MARKET : COMPANY RESEARCH ANALYSIS 17
FIGURE 6 U.S. PSYCHEDELIC DRUGS MARKET: INTERVIEW DEMOGRAPHICS 19
FIGURE 7 U.S. PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS 20
FIGURE 8 U.S. PSYCHEDELIC DRUGS MARKET: SEGMENTATION 24
FIGURE 9 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION AND INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS ARE DRIVING THE U.S. PSYCHEDELIC DRUGS MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 25
FIGURE 10 SYNTHETIC IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. PSYCHEDELIC DRUGS MARKET IN 2020 & 2027 26
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF U.S. PSYCHEDELIC DRUGS MARKET 32
FIGURE 12 MENTAL ILLNESS AMONG THE U.S. ADULTS IN 2018, BY DEMOGRAPHIC GROUP 35
FIGURE 13 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS IN 2018, BY DEMOGRAPHIC GROUP: 36
FIGURE 14 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS IN 2018, BY GENDER : 36
FIGURE 15 PREVALENCE OF DEPRESSIVE DISORDERS IN 2017 37
FIGURE 16 PREVALENCE OF ANXIETY DISORDERS IN 2017 37
FIGURE 17 PREVALENCE OF BIPOLAR DISORDER IN 2017 38
FIGURE 18 THE RIPPLE EFFECT OF MENTAL ILLNESS 38
FIGURE 19 MENTAL AND SUBSTANCE USE DISORDERS GLOBALLY IN 2017 40
FIGURE 20 PREVALENCE OF MENTAL HEALTH DISORDERS BY DISORDER TYPE IN WORLD IN 2017 41
FIGURE 21 MAGIC MUSHROOMS PRICES FOR RESEARCHERS IN THE U.S. 45
FIGURE 22 U.S. PSYCHEDELIC DRUGS MARKET: BY SOURCE, 2019 53
FIGURE 23 U.S. PSYCHEDELIC DRUGS MARKET: BY SOURCE, 2019-2027 (USD MILLION) 53
FIGURE 24 U.S. PSYCHEDELIC DRUGS MARKET: BY SOURCE, CAGR (2020-2027) 54
FIGURE 25 U.S. PSYCHEDELIC DRUGS MARKET: BY SOURCE, LIFELINE CURVE 54
FIGURE 26 U.S. PSYCHEDELIC DRUGS MARKET: BY TYPE, 2019 57
FIGURE 27 U.S. PSYCHEDELIC DRUGS MARKET: BY TYPE, 2019-2027 (USD MILLION) 57
FIGURE 28 U.S. PSYCHEDELIC DRUGS MARKET: BY TYPE, CAGR (2020-2027) 58
FIGURE 29 U.S. PSYCHEDELIC DRUGS MARKET: BY TYPE, LIFELINE CURVE 58
FIGURE 30 U.S. PSYCHEDELIC DRUGS MARKET: BY APPLICATION, 2019 61
FIGURE 31 U.S. PSYCHEDELIC DRUGS MARKET: BY APPLICATION, 2019-2027 (USD MILLION) 61
FIGURE 32 U.S. PSYCHEDELIC DRUGS MARKET: BY APPLICATION, CAGR (2020-2027) 62
FIGURE 33 U.S. PSYCHEDELIC DRUGS MARKET: BY APPLICATION, LIFELINE CURVE 62
FIGURE 34 U.S. PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, 2019 67
FIGURE 35 U.S. PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION) 67
FIGURE 36 U.S. PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2027) 68
FIGURE 37 U.S. PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE 68
FIGURE 38 U.S. PSYCHEDELIC DRUGS MARKET: BY DRUGS, 2019 72
FIGURE 39 U.S. PSYCHEDELIC DRUGS MARKET : BY DRUGS, 2019-2027 (USD MILLION) 72
FIGURE 40 U.S. PSYCHEDELIC DRUGS MARKET: BY DRUGS, CAGR (2020-2027) 73
FIGURE 41 U.S. PSYCHEDELIC DRUGS MARKET: BY DRUGS, LIFELINE CURVE 73
FIGURE 42 U.S. PSYCHEDELIC DRUGS MARKET: BY END USER, 2019 77
FIGURE 43 U.S. PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2027 (USD MILLION) 77
FIGURE 44 U.S. PSYCHEDELIC DRUGS MARKET: BY END USER, CAGR (2020-2027) 78
FIGURE 45 U.S. PSYCHEDELIC DRUGS MARKET: BY END USER, LIFELINE CURVE 78
FIGURE 46 U.S. PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2019 82
FIGURE 47 U.S. PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION) 82
FIGURE 48 U.S. PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027) 83
FIGURE 49 U.S. PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 83
FIGURE 50 U.S. PSYCHEDELIC DRUGS MARKET: COMPANY SHARE 2019 (%) 85
